Amniotic-Derived Treatments and Formulations.
Allograft
Amniotic fluid
Amniotic membrane
Sports medicine injury
Tissue regeneration
Journal
Clinics in sports medicine
ISSN: 1556-228X
Titre abrégé: Clin Sports Med
Pays: United States
ID NLM: 8112473
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
entrez:
24
11
2018
pubmed:
24
11
2018
medline:
14
12
2018
Statut:
ppublish
Résumé
In orthopedic sports medicine, amniotic-derived products have demonstrated promising preclinical and early clinical results for the treatment of tendon/ligament injuries, cartilage defects, and osteoarthritis. The amniotic membrane is a metabolically active tissue that has demonstrated anti-inflammatory, antimicrobial, antifibrotic, and epithelialization-promoting features that make it uniquely suited for several clinical applications. Although the existing clinical literature is limited, there are several ongoing clinical trials aiming to elucidate the specific applications and benefits of these products. This article reviews the current amniotic-derived treatment options and the existing literature on outcomes, complications, and safety profile of these products for use in sports medicine.
Identifiants
pubmed: 30466722
pii: S0278-5919(18)30074-7
doi: 10.1016/j.csm.2018.08.002
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
45-59Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.